4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000147
Director sold 1,666 shares at $19.13 ($31,871)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-11-15 | Sale 10b5-1 | −1,666 | $19.13 | $31,871 | 126,373 | D: show line 1 in the form |
| Open-market sales · 1,666 sh · avg $19.13 · $31,871 | |||||||
Loading xslF345X05/wk-form4_1700176428.xml…